National Health Investors, Inc. (NYSE:NHI - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the ten research firms that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $79.11.
NHI has been the topic of several recent analyst reports. Zacks Research raised shares of National Health Investors from a "strong sell" rating to a "hold" rating in a research note on Tuesday, September 29th. National Bank Financial set a $79.00 price target on National Health Investors in a report on Wednesday, September 9th. Weiss Ratings downgraded National Health Investors from a "hold (c+)" rating to a "hold (c)" rating in a report on Monday, November 16th. Bank of America lowered National Health Investors from a "buy" rating to an "underperform" rating and reduced their price target for the stock from $86.00 to $67.00 in a research note on Friday, November 13th. Finally, Wells Fargo & Company decreased their price objective on National Health Investors from $68.00 to $65.00 and set an "equal weight" rating on the stock in a report on Monday, November 16th.
Read Our Latest Research Report on National Health Investors
National Health Investors Stock Down 0.2%
National Health Investors stock opened at $61.30 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 13.59 and a quick ratio of 13.59. National Health Investors has a 1-year low of $59.05 and a 1-year high of $91.38. The company has a market cap of $3.01 billion, a PE ratio of 4.30, a price-to-earnings-growth ratio of 3.90 and a beta of 0.51. The stock's 50 day moving average price is $66.37 and its 200 day moving average price is $75.37.
National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings results on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share for the quarter, topping analysts' consensus estimates of $1.18 by $10.29. National Health Investors had a return on equity of 41.41% and a net margin of 152.82%. The business had revenue of $113.48 million for the quarter, compared to analysts' expectations of $68.53 million. On average, sell-side analysts predict that National Health Investors will post 4.72 EPS for the current fiscal year.
National Health Investors Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 6.0%. The ex-dividend date is Thursday, December 31st. National Health Investors's dividend payout ratio is presently 26.40%.
Insider Activity
In related news, CEO D. Eric Mendelsohn bought 1,500 shares of the stock in a transaction dated Tuesday, November 17th. The stock was acquired at an average price of $60.53 per share, for a total transaction of $90,795.00. Following the completion of the purchase, the chief executive officer owned 134,816 shares in the company, valued at $8,160,412.48. This represents a 1.13% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.70% of the company's stock.
Institutional Trading of National Health Investors
A number of hedge funds have recently made changes to their positions in NHI. BlackRock Inc. bought a new stake in National Health Investors in the second quarter valued at about $665,997,000. Bank of New York Mellon Corp acquired a new stake in National Health Investors during the second quarter valued at approximately $122,509,000. Bank of America Corp DE bought a new position in National Health Investors during the 2nd quarter worth approximately $77,738,000. Dimensional Fund Advisors LP lifted its holdings in National Health Investors by 2.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 686,249 shares of the real estate investment trust's stock worth $55,493,000 after buying an additional 18,164 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its holdings in National Health Investors by 21.3% during the 3rd quarter. Goldman Sachs Group Inc. now owns 285,194 shares of the real estate investment trust's stock worth $18,717,000 after buying an additional 50,116 shares during the last quarter. Institutional investors and hedge funds own 62.51% of the company's stock.
About National Health Investors
(
Get Free Report)
National Health Investors, Inc. NYSE: NHI is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI's portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.